Aflac (NYSE:AFL) price target raised to $48.00 by SunTrust Banks

Analyst Ratings For Aflac (NYSE:AFL)

Story continues below

Today, SunTrust Banks raised its price target on Aflac (NYSE:AFL) to $48.00 per share.

There are 10 Hold Ratings, 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Aflac (NYSE:AFL) is Hold with a consensus target price of $48.0909 per share, a potential 0.83% upside.

Some recent analyst ratings include

  • 1/2/2019-Aflac (NYSE:AFL) gets downgraded to Neutral by JPMorgan Chase & Co. with a price target of $51.00
  • 8/1/2018-Aflac (NYSE:AFL) gets upgraded to Buy by Sandler O’Neill with a price target of $52.00
  • 8/1/2018-Aflac (NYSE:AFL) had its Hold rating reiterated by Keefe, Bruyette & Woods with a $50.00 price target
  • On 12/21/2018 James Todd Daniels, Insider, sold 3,400 with an average share price of $44.14 per share and the total transaction amounting to $150,076.00.
  • On 12/20/2018 Richard Williams Jr, VP, sold 1,129 with an average share price of $43.97 per share and the total transaction amounting to $49,642.13.
  • On 9/13/2018 Douglas Wayne Johnson, Director, sold 2,000 with an average share price of $46.52 per share and the total transaction amounting to $93,040.00.
  • On 9/11/2018 Joseph L Moskowitz, Director, sold 1,500 with an average share price of $46.38 per share and the total transaction amounting to $69,570.00.
  • On 6/29/2018 Eric M Kirsch, Insider, sold 66,447 with an average share price of $43.31 per share and the total transaction amounting to $2,877,819.57.
  • On 3/26/2018 Charles B Knapp, Director, sold 10,000 with an average share price of $43.72 per share and the total transaction amounting to $437,200.00.
  • On 2/28/2018 June P Howard, Insider, sold 2,648 with an average share price of $90.33 per share and the total transaction amounting to $239,193.84.

About Aflac (NYSE:AFL)
Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan. The Aflac U.S. segment provides products designed to protect individuals from depletion of assets comprising accident, cancer, critical illness/care, hospital indemnity, fixed-benefit dental, and vision care plans; and loss-of-income products, such as life and short-term disability plans in the United States. The company sells its products through sales associates and brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

Recent Trading Activity for Aflac (NYSE:AFL)
Shares of Aflac closed the previous trading session at 47,70 −0,24 0,50 % with shares trading hands.

An ad to help with our costs